Prognostic value of cholesterol in women of different ages

Journal of Women's Health

Volumn 6, Issue 3, 1997, Pages 295-307

  Emond, Mary J ^a   Zareba, Wojciech ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART DISEASE; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MORTALITY; NORMAL HUMAN; PRIORITY JOURNAL; PROGNOSIS; STROKE;

EID: 0030840078     PISSN: 10597115     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1997.6.295     Document Type: Article

References (50)

1. Khachadurian AK. Role of cholesterol in atherosclerosis. In: Esfahani M, Swaney JB, eds. Advances in Cholesterol Research. Caldwell, NJ: The Teford Press, 1990.
2. Jacobs D, Blackburn H, Higgins M, Reed D, Iso H. Report of the Conference on Low Blood Cholesterol: Mortality associations. Circulation 1992;86:1046.
3. Frank JW, Reed DM, Grove JS, Benfante R. Will low-ering population levels of serum cholesterol affect total mortality? Expectations from the Honolulu Heart Program. J Clin Epidemiol 1992;45:333.
4. Simes RJ. Low cholesterol and risk of non-coronary mortality. Aust NZ J Med 1994;24:113.
5. Law MR, Thompson SG, Wald NJ. Assessing possible hazards of reducing serum cholesterol. Br Med J 1994;308:373.
6. Neaton JD, Blackburn H, Jacobs D, et al. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992;152:1490.
7. Law MR, Thompson SG. Low serum cholesterol and the risk of cancer: An analysis of the published prospective studies. Cancer Causes Control 1991; 2:253.
8. Smith GD, Shipley MJ, Marmot MG, Rose G. Plasma cholesterol concentration and mortality. The Whitehall Study. JAMA 1992;267:70.
9. Kreger BE, Anderson KM, Schatzkin A, Splansky GL. Serum cholesterol level, body mass index, and the risk of colon cancer. The Framingham Study. Cancer 1992;70:1038.
10. Chang AK, Barrett-Connor E, Edelstein S. Low plasma cholesterol predicts an increased risk of lung cancer in elderly women. Prev Med 1995;24:557.
11. Muldoon MF, Rossouw JE, Manuck SB, Glueck CJ, Kaplan JR, Kaufman PG. Low or lowered cholesterol and risk of death from suicide and trauma. Metabolism 1993;42(9 Suppl 1):45.
12. Holme I. An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence [published erratum appears in Circulation 1991;84:2610]. Circulation 1990;(82):1916.
13. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials. Br Med J 1990;301:309.
14. Walsh JME, and Grady D. Treatment of hyperlipidemia in women. JAMA 1995;274:1152.
15. Lemer DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham population. Am Heart J 1986;11:383.
16. Kannel WB. Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham Study. Am Heart J 1987;114:413.
17. Wingard DL, Cohn BA, Kaplan GA, Cirilli PM, and Cohen RD. Sex differences in morbidity and mortality risk examined by age and cause in the same cohort. Am J Epidemiol 1989;130:601.
18. Nikkila M, Heikkinen J. Serum cholesterol, high-density lipoprotein cholesterol and five-year survival in elderly people. Age Ageing 1990;19:403.
19. Barrett-Connor E. Hypercholesterolemia predicts early death from coronary heart disease in elderly men but not women. The Rancho Bernardo Study. Ann Epidemiol 1992;2:77.
20. Harris T, Feldman JJ, Kleinman JC, Ettinger WH, Makuc DM, Schatzkin AG. The low cholesterol-mortality association in a national cohort. J Clin Epidemiol 1992;45:595.
21. Higgins M, Keller JB. Cholesterol, coronary heart disease, and total mortality in middle-aged and elderly men and women in Tecumseh. Ann Epidemiol 1992;2:69.
22. White AD, Hames CG, Tyroler HA. Serum cholesterol and 20-year mortality in black and white men and women aged 65 and older in the Evans County Heart Study. Ann Epidemiol 1992;2:85.
23. Kronmal RA, Cain KC, Ye Z, Omenn GS. Total serum cholesterol levels and mortality risk as a function of age. Arch Intern Med 1992;153:1065.
24. Dawber TR. The Framingham Study. Cambridge, MA: Harvard University Press, 1980.
25. Chambless L, Doring A, Filipiak B, Keil U. Determinants of HDL-cholesterol and the HDL-cholesterol/ total cholesterol ratio. Results of the Lubeck Blood Pressure Study. Int J Epidemiol 1990;19:578.
26. Kannel WB, D'Agostino RB, Wilson PWF, Belanger AJ, Gagnon DR. Diabetes, fibrinogen and risk of cardiovascular disease: The Framingham experience. Am Heart J 1990;120:672.
27. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991;265:627.
28. Cupples, LA, D'Agostino RB. The Framingham Study. An epidemiological investigation of cardiovascular disease. Section 34. NIH Publication No. 87-2703, 1987.
29. Rothman KJ. Modern epidemiology. Boston: Little, Brown, 1986.
30. Emond MJ, Self SG. An efficient estimator for the generalized semilinear model. J Am Stat Assn, In press.
31. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: Wiley & Sons, 1980.
32. Anderson KM, Castelli WP. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA 1987;257:2176.
33. Krumholz HM, Seeman TE, Merrill SS, et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA 1995;273:1335.
34. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatments of high blood cholesterol in adults (adult treatment panel II). JAMA 1993;269:3015.
35. Jacobs DR. Why is low blood cholesterol associated with risk of nonatherosclerotic disease death? Annu Rev Public Health 1993;14:95.
36. LaRosa JC. Cholesterol lowering, low cholesterol, and mortality. Am J Cardiol 1993;72:776.
37. Oranje WA, Wolffenbuttel BH. Low cholesterol and excess mortality: A real relationship? Neth J Med 1993;42:89.
38. Sullivan D. Cholesterol and non-cardiovascular disease: Basic science. Aust NZ J Med 1994;24:92.
39. Meilahn EN, Ferrell RE. "Naturally occurring" low blood cholesterol and excess mortality. Coron Artery Dis 1993;4:843.
40. Atkins D. Cholesterol reduction and the risk of stroke: A metaanalysis of randomized controlled trials [masters thesis (no. 40071)]. Master's thesis, University of Washington, Seattle, WA, 98195, 1993.
41. Iso H, Jacobs DR, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 1989;32:904.
42. Yano K, Reed DM, MacLean CL. Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. Stroke 1989;20:1460.
43. Shimamoto T, Komachi Y, Inada H, et al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989;79:503.
44. Iribarren C, Sharp D, Burchfiel CM, Sun P, Dwyer JH. Association of serum total cholesterol with coronary disease and all-cause mortality: Multivariate correction for bias due to measurement error. Am J Epidemiol 1996;143:463.
45. D'Agostino RB, Belanger AJ, Kannel WB, Higgins M. Role of smoking in the U-shaped relation of cholesterol to mortality in men. The Framingham Study. Am J Epidemiol 1995;141:822.
46. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandanavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383.
47. Castelli WP, Anderson K, Wilson PWF, Levy D. Lipids and risk of coronary heart disease in the Framingham Study. Ann Epidemiol 1992;2:23.
48. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE. Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women. Am J Cardiol 1991;68:1646.
49. Manolio TA, Pearson TA, Wenger NK, Barrett-Connor E, Payne GH, Harlan WR. Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann Epidemiol 1992;2:161.
50. Knapp RG, Sutherland SE, Keil JE, Rust RF, Lackland DT. A comparison of the effects of cholesterol on CHD mortality in black and white women: Twenty-eight years of follow-up in the Charleston Heart Study. J Clin Epidemiol 1992;45:1119.